Author:
Mendes Diana,Machira Krishnan Sheeja,O’Brien Esmé,Padgett Thomas,Harrison Cale,Strain W. David,Manca Andrea,Ustianowski Andrew,Butfield Rebecca,Hamson Elizabeth,Reynard Charlie,Yang Jingyan
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Singanayagam A, Hakki S, Dunning J, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22(2):183–95.
2. Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53:101624.
3. Public Health England. COVID-19 vaccine surveillance report published. 2021. https://www.gov.uk/government/news/covid-19-vaccine-surveillance-report-published. Accessed 05 Sep 2023.
4. GOV.UK. JCVI statement regarding a COVID-19 booster vaccine programme for winter 2021 to 2022. 2021. https://www.gov.uk/government/publications/jcvi-statement-september-2021-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-statement-regarding-a-covid-19-booster-vaccine-programme-for-winter-2021-to-2022. Accessed 28 June 2023.
5. Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–12.